Fibrin clot properties and thrombus composition in cirrhosis
Patients with cirrhosis frequently acquire profound hemostatic alterations, which may affect thrombus quality and composition—factors that determine the susceptibility to embolization and fibrinolysis. In this narrative review, we describe in vitro studies on fibrin clot formation and quantitative a...
Gespeichert in:
Veröffentlicht in: | Research and practice in thrombosis and haemostasis 2023-01, Vol.7 (1), p.100055-100055, Article 100055 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Patients with cirrhosis frequently acquire profound hemostatic alterations, which may affect thrombus quality and composition—factors that determine the susceptibility to embolization and fibrinolysis. In this narrative review, we describe in vitro studies on fibrin clot formation and quantitative and qualitative changes in fibrinogen in patients with cirrhosis, and describe recent findings on the composition of portal vein thrombi in patients with cirrhosis. Patients with mild cirrhosis have increased thrombin generation capacity and plasma fibrinogen levels, which may be balanced by delayed fibrin polymerization and decreased factor XIII levels. With progressing illness, plasma fibrinogen levels decrease, but thrombin generation capacity remains elevated. Fibrinogen is susceptible to posttranslational protein modifications and is, for example, hypersialylated and carbonylated in patients with cirrhosis. Despite changes in thrombin generation, factor XIII levels and the fibrinogen molecule, fibrin fiber thickness, and density are normal in patients with cirrhosis. Paradoxically, fibrin clot permeability in patients with cirrhosis is decreased, possibly because of posttranslational protein modifications. Most patients have normal fibrinolytic potential. We have recently demonstrated that portal vein thrombosis is likely a misnomer as the material that may obstruct the cirrhotic portal vein frequently consists of a thickened portal vein wall, rather than a true thrombus. Patients with cirrhosis often have thrombocytopenia and anemia, which may also affect clot stability and composition, but the role of cellular components in clot quality in cirrhosis has not been extensively studied. Finally, we summarize abstracts on fibrin formation and clot quality that were presented at the ISTH 2022 meeting in London.
•Patients with cirrhosis have normal to increased thrombin generation and plasma fibrinogen levels.•Fibrin formation is delayed and factor XIII levels are decreased in cirrhosis.•Fibrin fiber thickness and density are normal in cirrhosis, but clot permeability is decreased.•Fibrin clot quality in acutely ill patients with cirrhosis differs from that of patients with stable cirrhosis. |
---|---|
ISSN: | 2475-0379 2475-0379 |
DOI: | 10.1016/j.rpth.2023.100055 |